Molecular epidemiology of clostridium difficile in a tertiary hospital of China

Journal of Medical Microbiology

Volumn 63, Issue PART 4, 2014, Pages 562-569

  Chen, Yun Bo ^a,b   Gu, Si Lan ^a,b   Wei, Ze Qing ^a,b   Shen, Ping ^a,b   Kong, Hai Sheng ^a,b   Yang, Qing ^a,b   Li, Lan Juan ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; TERTIARY CARE CENTER;

BACTERIAL TOXINS; CHINA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; FEMALE; GENOTYPE; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; RIBOTYPING; TERTIARY CARE CENTERS;

EID: 84897836369     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.068668-0     Document Type: Article

References (25)

1. Bartlett, J. G. (2002). Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346, 334-339.
2. Bartlett, J. G. (2008). Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 46 (Suppl 1), S4-S11.
3. Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T. & Kuijper, E. J. (2011). Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377, 63-73.
4. Chung, C. H., Wu, C. J., Lee, H. C., Yan, J. J., Chang, C. M., Lee, N. Y., Chen, P. L., Lee, C. C., Hung, Y. P. & Ko, W. C. (2010). Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis. J Microbiol Immunol Infect 43, 119-125.
5. Dong, D., Zhang, L., Chen, X., Jiang, C., Yu, B., Wang, X. & Peng, Y. (2013). Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium difficile from a Chinese tertiary hospital. Int J Antimicrob Agents 41, 80-84.
6. Gorschlüter, M., Glasmacher, A., Hahn, C., Schakowski, F., Ziske, C., Molitor, E., Marklein, G., Sauerbruch, T. & Schmidt-Wolf, I. G. (2001). Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 33, 786-791.
7. Griffiths, D., Fawley, W., Kachrimanidou, M., Bowden, R., Crook, D. W., Fung, R., Golubchik, T., Harding, R. M., Jeffery, K. J. & other authors (2010). Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 48, 770-778.
8. He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D. & other authors (2013). Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45, 109-113.
9. Huang, H., Wu, S., Wang, M., Zhang, Y., Fang, H., Palmgren, A. C., Weintraub, A. & Nord, C. E. (2009). Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Int J Antimicrob Agents 33, 339-342.
10. Kato, H., Kato, N., Watanabe, K., Iwai, N., Nakamura, H., Yamamoto, T., Suzuki, K., Kim, S. M., Chong, Y. & Wasito, E. B. (1998). Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36, 2178-2182.
11. Killgore, G., Thompson, A., Johnson, S., Brazier, J., Kuijper, E., Pepin, J., Frost, E. H., Savelkoul, P., Nicholson, B. & other authors (2008). Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46, 431-437.
12. Kim, H., Jeong, S. H., Roh, K. H., Hong, S. G., Kim, J. W., Shin, M. G., Kim, M. N., Shin, H. B., Uh, Y. & other authors (2010). Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 30, 491-497.
13. Kim, J., Pai, H., Seo, M. R. & Kang, J. O. (2012). Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis 12, 109.
14. Lemee, L., Dhalluin, A., Pestel-Caron, M., Lemeland, J. F. & Pons, J. L. (2004). Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol 42, 2609-2617.
15. Lemée, L., Bourgeois, I., Ruffin, E., Collignon, A., Lemeland, J. F. & Pons, J. L. (2005). Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. Microbiology 151, 3171-3180.
16. Loo, V. G., Bourgault, A. M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H. & other authors (2011). Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365, 1693-1703.
17. Pothoulakis, C. (1996). Pathogenesis of Clostridium difficileassociated diarrhoea. Eur J Gastroenterol Hepatol 8, 1041-1047.
18. Rupnik, M. (2008). Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32, 541-555.
19. Rupnik, M., Kato, N., Grabnar, M. & Kato, H. (2003). New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41, 1118-1125.
20. Rupnik, M., Wilcox, M. H. & Gerding, D. N. (2009). Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7, 526-536.
21. Shin, B. M., Kuak, E. Y., Yoo, H. M., Kim, E. C., Lee, K., Kang, J. O., Whang, D. H. & Shin, J. H. (2008). Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005. J Med Microbiol 57, 697-701.
22. Søes, L. M., Brock, I., Persson, S., Simonsen, J., Pribil Olsen, K. E. & Kemp, M. (2012). Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. Eur J Clin Microbiol Infect Dis 31, 185-192.
23. Stubbs, S., Rupnik, M., Gibert, M., Brazier, J., Duerden, B. & Popoff, M. (2000). Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186, 307-312.
24. Walker, A. S., Eyre, D. W., Wyllie, D. H., Dingle, K. E., Griffiths, D., Shine, B., Oakley, S., O'Connor, L., Finney, J. & other authors (2013). Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 56, 1589-1600.
25. Yan, Q., Zhang, J., Chen, C., Zhou, H., Du, P., Cui, Z., Cen, R., Liu, L., Li, W. & other authors (2013). Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China. Epidemiol Infect 141, 195-199.